Market closedNon-fractional

InspireMD/NSPR

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About InspireMD

InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.

Ticker

NSPR

Sector

Healthcare

Trading on

NASDAQ

Industry

Health Care Equipment and Supplies

Headquarters

Tel Aviv, Israel

Employees

68

InspireMD Metrics

BasicAdvanced
$60M
Market cap
-
P/E ratio
-$0.74
EPS
0.97
Beta
-
Dividend rate
$60M
0.97
7.896
7.304
2.605
4.17
-48.78%
-93.55%
11.367
1.59
1.59
-4.291
23.91%
-67.88%
38.14%
-42.93%

What the Analysts think about InspireMD

Analyst Ratings

Majority rating from 1 analysts.
Buy

InspireMD Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-466.66% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$1.5M
-11.76%
Net income
-$7M
29.63%
Profit margin
-466.66%
46.91%

InspireMD Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 40.00%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.25
-$0.16
-$0.17
-$0.22
-
Expected
-$0.32
-$0.16
-$0.20
-$0.16
-$0.19
Surprise
-20.00%
-3.23%
-17.95%
40.00%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for InspireMD stock?

InspireMD (NSPR) has a market cap of $60M as of July 06, 2024.

What is the P/E ratio for InspireMD stock?

The price to earnings (P/E) ratio for InspireMD (NSPR) stock is 0 as of July 06, 2024.

Does InspireMD stock pay dividends?

No, InspireMD (NSPR) stock does not pay dividends to its shareholders as of July 06, 2024.

When is the next InspireMD dividend payment date?

InspireMD (NSPR) stock does not pay dividends to its shareholders.

What is the beta indicator for InspireMD?

InspireMD (NSPR) has a beta rating of 0.97. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

Buy or sell InspireMD stock

Buy or sell InspireMD stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing